Get access to our best features
Information about prnewswire.comWhere is prnewswire.com located?Headquarters: United Statesprnewswire.com's Website

Ownership

Who owns prnewswire.com?
Media Conglomerate: Cision
Learn more about Ownership categories.

Factuality

How credible is the news from prnewswire.com?
Learn more about Factuality Ratings.

Media Bias Ratings

Does prnewswire.com lean left or right?
Learn more about Media Bias Ratings.

Top prnewswire.com News

FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trial
Alzheimer · Washington

FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trial

59% Center coverage: 189 sources
The Food and Drug Administration on Friday approved an Alzheimer’s drug shown in clinical trials to slow cognitive decline in patients in the early stages of the illness.See the Story
Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference - Crinetics Pharmaceuticals (NASDAQ:CRNX)

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference - Crinetics Pharmaceuticals (NASDAQ:CRNX)

100% Center coverage: 3 sources
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 41st Annual J.P. Morgan Healthcare Conference Call January 9, 2023 11:15 AM ET Company Participants Reshma Kewalramani - Chief Executive Officer and President Charlie Wagner - Chief Financial Officer Stuart Arbuckle - Chief Operating Officer David Altshuler - Executive Vice President, Global Research, and Chief Scientific OfficerSee the Story
Esperion Outlines Upcoming Milestones and Announces Preliminary Fourth Quarter 2022 Financial Results - Esperion Therapeutics (NASDAQ:ESPR)
Business

Esperion Outlines Upcoming Milestones and Announces Preliminary Fourth Quarter 2022 Financial Results - Esperion Therapeutics (NASDAQ:ESPR)

67% Center coverage: 3 sources
Nova expects to release its financial results for the fourth quarter and full year of 2022 before the Nasdaq market opens on February 15, 2023. Eitan Oppenhaim, President and Chief Executive Officer, and Dror David, Chief Financial Officer, will host a conference call to review the Company's financial results. The conference call will be available via a live webcast from a link on Nova's Investor Relations website.See the Story

Blindspots

Latest News Stories

Breaking News Topics Related to prnewswire.com